This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Emergency myelopoiesis in murine arthritis results in cell-intrinsic changes in dendritic cell development and function.
iScience · 2026
Implementation and Evaluation of a Virtual Rheumatology Training Program in East Africa.
The Journal of rheumatology · 2025
Predicting Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Using an Extended Set of Clinical Variables: An Unmet Need.
International journal of rheumatic diseases · 2025
Latest funding
- $1,040,400
Investigating the anti-fibrotic effects of human multipotent mesenchymal stromal cells.
CIHR · 2024 · Nominated PI
- $5,222,039
Immunogenicity and safety of COVID-19 vaccine Co-administration and Interval in Immunocompromised hosts (CO2I2 Trial).
CIHR · 2023 · Principal investigator
- $1,305,510
Immunogenicity and safety of COVID-19 vaccine Co-administration and Interval in Immunocompromised hosts (CO2I2 Trial).
CIHR · 2023 · Principal investigator
38 publications.
Emergency myelopoiesis in murine arthritis results in cell-intrinsic changes in dendritic cell development and function.
Tung LT, Jiang RR, Pozzebon B, Mancini M, Droin L, Yousefi M, Kim JEJ, Mousa M, Liang Y, Krawczyk CM, Colmegna I, Malo D, Langlais D, Vidal SM, Nijnik A
Implementation and Evaluation of a Virtual Rheumatology Training Program in East Africa.
Hitchon CA, Scuccimarri R, Colmegna I, Masaisa F, Mody GM, Michele Meltzer and the Rheumatology For All Rwanda Program Group
Predicting Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Using an Extended Set of Clinical Variables: An Unmet Need.
Nguyen N, Bernatsky S, Colmegna I, Berger C, Carrier N, Allard-Chamard H, Liang P, Roux S, Boire G, Hudson M
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides
Ye C, Nikolic RPA, Choi M, Fifi-Mah AV, Graham J, O'Neil LJ, Kobza A, Lau KCK, Arreola LG, Pardo JP
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases
Ye C, Nikolic RPA, Choi M, Fifi-Mah AV, Graham J, O'Neil LJ, Kobza A, Lau KCK, Arreola LG, Pardo JP
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) Study
Tan J, Bernatsky S, Lee JLF, Fortin PR, Dayam RM, Gingras A-C, Colmegna I, Bowdish DME, Berger C, Chan D
Sex differences in COVID-19 vaccine confidence in people living with HIV in Canada.
Lu J, Vulesevic B, Burchell AN, Singer J, Needham J, Yang Y, Qian H, Chambers C, Samji H, Colmegna I, Del Canto S, Godin GH, Habanyama M, Hui SSC, Kroch A, Mandarino E, Margolese S, Martin C, Owino M, Lau E, Mohammadi T, Zhang W, Pelaez S, Kovacs C, Benko E, Cooper CL, Anis AH, Costiniuk CT, COVAXHIV Study Group
When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study.
Bowdish DME, Chandran V, Hitchon CA, Kaplan GG, Avina-Zubieta JA, Fortin PR, Larché MJ, Boire G, Gingras A-C, Dayam RM
How Safe Are COVID-19 Vaccines in Individuals with Immune-Mediated Inflammatory Diseases? The SUCCEED Study
Tsyruk O, Kaplan GG, Fortin PR, Hitchon CA, Chandran V, Larché MJ, Avina-Zubieta A, Boire G, Colmegna I, Lacaille D
Duration of Postvaccination Neutralizing Antibodies to SARS‐CoV‐2 and Medication Effects: Results from the Safety and Immunogenicity of COVID‐19 Vaccination in Systemic Immune‐Mediated Inflammatory Diseases Cohort Study
Habib R, Dayam RM, Hitchon C, Chandran V, Fortin PR, Boire G, Bowdish DME, Gingras A, Flamand L, Larché MJ
Investigating the anti-fibrotic effects of human multipotent mesenchymal stromal cells.
Principal investigators: Colmegna, Ines; Langlais, David; Martin, James G
Keywords: Anti-Fibrosis; Cellular Therapy; Fibrosis; Fibrosis Resolution; Lung Fibrosis; Multipotent Mesenchymal Stromal Cells; Scleroderma; Skin Fibrosis; Systemic Bleomycin Minipump Model
Immunogenicity and safety of COVID-19 vaccine Co-administration and Interval in Immunocompromised hosts (CO2I2 Trial).
Principal investigators: Sapir-Pichhadze, Ruth; Stalker, Leanne; Colmegna, Ines; Costiniuk, Cecilia T; Suri, Rita
Keywords: Cellular Immunity; Cost Effectiveness; Covid-19; Humoral Immunity; Immunogenicity; Influenza; Neutralization; Quality Of Life; Safety; Vaccine
Immunogenicity and safety of COVID-19 vaccine Co-administration and Interval in Immunocompromised hosts (CO2I2 Trial).
Principal investigators: Sapir-Pichhadze, Ruth; Stalker, Leanne; Colmegna, Ines; Costiniuk, Cecilia T; Suri, Rita
Keywords: Cellular Immunity; Cost Effectiveness; Covid-19; Humoral Immunity; Immunogenicity; Influenza; Neutralization; Quality Of Life; Safety; Vaccine
COVID-19 Vaccine Confidence Among At-Risk and Under-Vaccinated Groups Within HIV and Rheumatic diseases (CONFIDENCE)
Principal investigators: Colmegna, Ines; Costiniuk, Cecilia T; Pelaez, Sandra
Keywords: Covid Vaccines; Hiv; Language Barriers; Migrants; Systemic Autoimmune Rheumatic Diseases; Transnationalism; Vaccine Acceptance; Vaccine Hesitancy; Women
Hematopoietic Stem and Progenitor Cells as Mediators of Trained Immunity in Rheumatoid Arthritis
Principal investigators: Nijnik, Anastasia; Colmegna, Ines; Langlais, David
Keywords: Epigenetics; Hematopoietic Stem And Progenitor Cells; Inflammation; Innate Immunity; Rheumatoid Arthritis; Transcriptional Regulation
Phase I/II randomized controlled clinical trial of umbilical cord-derived mesenchymal stromal cells in refractory systemic sclerosis
Principal investigators: Hudson, Marie; Colmegna, Ines; Farge, Dominique
Keywords: Mesenchymal Stem Cells; Randomized Clinical Trial; Systemic Sclerosis
Unraveling the Mechanism of Action of the Adiponectin Receptor Pathways in a Humanized in vitro Model of Carotid Plaque Instability
Principal investigators: Daskalopoulou, Stella S; Cailhier, Jean-Francois
Keywords: Adiponectin; Adiponectin Receptors; Atherosclerosis; Carotid Plaque Histology; Carotid Plaque Instability; Gene And Protein Expression; Immunomodulation; Macrophage Polarization; Monocytes; Stroke
Meta-Epigenomic Research In Autoimmune Diseases - The M-Eriad Program
Principal investigators: Hudson, Marie; Baron, Murray; Bar-Or, Amit; Bernatsky, Sasha R; Colmegna, Ines; Madrenas, Joaquin; Pastinen, Tomi; Piccirillo, Ciriaco A
Keywords: Autoimmune Diseases; Environment; Epigenome; Genome; Metagenome; Multiple Sclerosis; Rheumatoid Arthritis; Systemic Lupus Erythematosus; Systemic Sclerosis
Incidence, symptoms and impact of flare in patients with early rheumatoid arthritis: Insights from the Canadian early ArThritis CoHort(CATCH)
Principal investigators: Bartlett, Susan J
Keywords: Disability; Disease Progression; Flares; Health Outcomes; Patient-Reported Outcomes; Rheumatoid Arthritis
Rheumatoid Arthritis and Immune Dysfunction: The Role of Damaged Hematopoietic Stem and Progenitor Cells
Principal investigators: Colmegna, Ines
Keywords: Aging; Cytokines; Hematopoietic Stem And Progenitor Cells; Mesenchymal Stromal Cells; Rheumatoid Arthritis
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Rheumatology
- Psychiatry
- Epidemiology Division
- Human Genetics
- Internal Medicine
- Department of Molecular Genetics
- Other
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Sasha Bernatsky
Medicine
16 shared papers, latest 2025
Marie Hudson
Psychiatry
14 shared papers, latest 2025
Sasha Bernatsky
Faculty
13 shared papers, latest 2025
Tomi Pastinen
Human Genetics
5 shared papers, latest 2019
Nancy Maltez
Faculty
5 shared papers, latest 2025
Sandra Pelaez
Medicine
4 shared papers, latest 2024
Carol Hitchon
Internal Medicine
4 shared papers, latest 2024
Margaret Larche
Medicine
4 shared papers, latest 2025
Carrie Ye
Medicine
3 shared papers, latest 2025
Sabrina Hoa
Medicine
3 shared papers, latest 2025
Sabrina Hoa
Psychiatry
3 shared papers, latest 2025
Dominique Farge
Faculty
3 shared papers, latest 2022
Vinod Chandran
Rheumatology
3 shared papers, latest 2024
Dawn Bowdish
Medicine
3 shared papers, latest 2025
Anne-Claude Gingras
Department of Molecular Genetics
3 shared papers, latest 2025
Janet Pope
Department of Epidemiology and Biostatistics
2 shared papers, latest 2022
Hasina Samji
Health Sciences
2 shared papers, latest 2024
Shari Margolese
Faculty
2 shared papers, latest 2024
Abigail Kroch
Epidemiology Division
2 shared papers, latest 2024
Sophie Roux
Rhumatologie
2 shared papers, latest 2025
Philip Awadalla
Occupational and Environmental Health
2 shared papers, latest 2020
Wei Zhang
School of Population and Public Health
2 shared papers, latest 2024
Diane Lacaille
Dermatology and Skin Science
2 shared papers, latest 2024
Louis Flamand
Microbiologie et immunologie
2 shared papers, latest 2024
Faiza Khokhar
Medicine
2 shared papers, latest 2025
Anastasia Nijnik
Physiology
1 shared papers, latest 2026
Robert Rottapel
Medical Biophysics
1 shared papers, latest 2021
Robby Nieuwlaat
Health Research Methods, Evidence, and Impact
1 shared papers, latest 2021
Peter Tugwell
School of Epidemiology and Public Health
1 shared papers, latest 2021
Mark Loeb
Pathology & Molecular Medicine
1 shared papers, latest 2021
Dominik Mertz
Medicine
1 shared papers, latest 2021
Holger Schunemann
Health Research Methods, Evidence, and Impact
1 shared papers, latest 2021
Reza Donald Mirza
Medicine
1 shared papers, latest 2021
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.